Hologic, Inc. provided preliminary revenue guidance for first fiscal quarter ended December 25, 2021. For the quarter, the company expects to report total revenues of approximately $1,471.1 million, a decrease of (8.6%) compared to the prior year period, or (8.2%) in constant currency. These preliminary results compare to the Company's most recent guidance range of $1,100 to $1,150 million, which was provided on November 1, 2021.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
74.12 USD | +0.87% |
|
-0.18% | +3.74% |
Jul. 02 | Evercore ISI Adjusts Price Target on Hologic to $76 From $78, Maintains In-line Rating | MT |
Jun. 27 | Stephens Initiates Coverage on Hologic With Overweight Rating, $87 Price Target | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.74% | 17.29B | |
+1.75% | 206B | |
+3.42% | 177B | |
+31.54% | 157B | |
+32.16% | 112B | |
+1.71% | 64.63B | |
+21.08% | 55.63B | |
-1.61% | 47.57B | |
-9.11% | 36.87B | |
-0.34% | 35.18B |
- Stock Market
- Equities
- HOLX Stock
- News Hologic, Inc.
- Hologic, Inc. Provides Preliminary Revenue Guidance for First Fiscal Quarter Ended December 25, 2021